Oyster Therapeutics Completes $60 million Series A-2 Funding
LLY Lilly(Eli) & Co
$1415.55 -1.13%
View chart & analysis → - 1Oyster Therapeutics has secured $60 million in Series A-2 funding.
- 24BIO Capital led the investment.
- 3Oyster Therapeutics has entered into a sponsored research partnership with Massachusetts General Hospital.
So what's the key point?
Oyster Therapeutics received $60 million in investment. 4BIO Capital led the round, and the company will conduct research in partnership with a hospital.
Source Pharmaceutical Business Review · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.